Your browser doesn't support javascript.
loading
Lack of a US Food and Drug Administration indication should not limit access to appropriate treatment.
Albrecht, Joerg; Adamson, Adewole S; Barbieri, John S; Bennett, Daniel D; Kiracofe, Elizabeth A; Kourosh, A Shadi; Leslie, Kieron S; Merola, Joseph F; Nguyen, Josephine; Siegfried, Elaine; Strickland, Nicole; Olbricht, Suzanne; Asgari, Maryam M.
Afiliação
  • Albrecht J; Division of Dermatology, Department of Medicine, J.H. Stroger Hospital of Cook County, Chicago, Illinois; Department of Dermatology, Rush Medical College, Chicago, Illinois. Electronic address: jalbrecht@cookcountyhhs.org.
  • Adamson AS; Department of Dermatology, Department of Medicine, Dell Medical School at The University of Texas at Austin, Austin, Texas.
  • Barbieri JS; Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Bennett DD; Department of Dermatology, University of Wisconsin - Madison, Madion, Wisconsin.
  • Kiracofe EA; Illinois Dermatology Institute, Chicago, Illinois.
  • Kourosh AS; Department of Dermatology, Harvard Medical School, Boston, Massachusetts.
  • Leslie KS; Department of Dermatology, University of California, San Francisco, California.
  • Merola JF; Department of Dermatology, Harvard Medical School, Boston, Massachusetts; Department of Medicine, Division of Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Nguyen J; Captain James A. Lovell Federal Health Care Center, Chicago, Illinois; Uniformed Services University of the Health Sciences, Bethesda, Maryland.
  • Siegfried E; Department of Pediatrics, Saint Louis University, St. Louis, Missouri; Cardinal Glennon Children's Hospital, St. Louis, Missouri.
  • Strickland N; Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Olbricht S; Department of Dermatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Asgari MM; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
J Am Acad Dermatol ; 80(2): 577-578, 2019 02.
Article em En | MEDLINE | ID: mdl-30244066
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatopatias / United States Food and Drug Administration / Fármacos Dermatológicos / Uso Off-Label / Acessibilidade aos Serviços de Saúde Limite: Adult / Child / Female / Humans / Male País/Região como assunto: America do norte Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatopatias / United States Food and Drug Administration / Fármacos Dermatológicos / Uso Off-Label / Acessibilidade aos Serviços de Saúde Limite: Adult / Child / Female / Humans / Male País/Região como assunto: America do norte Idioma: En Ano de publicação: 2019 Tipo de documento: Article